Dr. John Cush RheumNow
7 years 7 months ago
Prevalence of gout continues to rise. NHANES data say prevalence of gout is 9.2 million inUS adults (2015-2016) (5.9 mill men; 3.3 mil women); hyperuricemia prevalences is 20.0%. ULT use in gout was 33% between 2007-2014. https://t.co/nDEJM7gTGA
Dr. John Cush RheumNow
7 years 7 months ago
A review of OP Guidelines, published in Osteoporosis International, shows only 27 of the 70 guidelines patient Beliefs, Values or Perceptions. https://t.co/zGoX2aaxdP
Dr. John Cush RheumNow
7 years 7 months ago
AAOS meeting presentation of 114,698 TKR pts shows younger pts (age <40) have a 3 fold greater risk of early mechanical complications & are 63% more likely to be rehospitalized w/in 90D. Younger have more obesity, DM, inflamm arthritis, ACL surgery https://t.co/DoePD5GXl9
Rates of resistant hypertension were doubled among patients with systemic lupus erythematosus (SLE), significantly increasing their mortality risks, a retrospective single-center study found.
Among patients with SLE, the prevalence of resistant hypertension was 10.2% compared with 5.3% among controls (OR 2.02, 95% CI 1.60-2.55, P<0.0001), according to Cecilia P. Chung, MD, and colleagues from Vanderbilt University in Nashville.
Dr. John Cush RheumNow
7 years 7 months ago
The risk of acute coronary syndromes in inflammatory myositis patients is doubled, especially in the first year (vs general population) and in older individuals. (HR 2.4; 1.8-3.2) - 7% IIM vs 3.3% in controls at 5 yrs. https://t.co/lCWGfm81EN
Dr. John Cush RheumNow
7 years 7 months ago
QD Clinic - Goldilocks and Osteoarthritis | RheumNow - Finding the Right Ddose for the Right Patient? https://t.co/SMmVYDxPeX
The mortality rate from end- stage renal disease (ESRD) in lupus nephritis (LN) patients has significantly decreased in the last decade.
Plug Into RheumNow Live
A Preview of the FIRST RheumNow Live!
Dr. John Cush RheumNow
7 years 7 months ago
FREE Online viewing of RheumNow Live - Friday 3/22 at 1pm EST. 2 hr discussion blocks on RA, PsA, AS, SLE, Vasculitis. 10 "TED" talks interspersed from Cush, Calabrese, Van Vollenhoven, Schett, Matteson, Wolfe, Oransky,etc. SEE YOU THERE OR REGISTER HERE https://t.co/lbrJ0Dp1Hb
Published guidelines warn that treating osteoarthritis (OA) with opioids and benzodiazepines can boost patients' risk of falling. Nevertheless, physicians in a large health system were prescribing those drugs for the condition nearly a third of the time, often in the vulnerable elderly, according to a study reported here.
Jeff Sparks jeffsparks
7 years 7 months ago
Rheumatologists are the happiest specialists! https://t.co/C6aaHWq7qf @ACRheum Choose Rheumatology and Be Happy! @alhkim
Dr. John Cush RheumNow
7 years 7 months ago
Study of 151,305 pts from Clinical Practice Research Datalink, shows that THR/TKR patients exposed to statins for 1-5 years had ~25% reduced risk of arthroplasty revision (HR 0.74 (0.62, 0.88)). https://t.co/AQhKHuAwkD
Dr. John Cush RheumNow
7 years 7 months ago
Pain signaling via NMDA receptors in the brain can be treated with drugs that block NMDA receptors (ketamine, methadone, memantine, amantadine, dextromethorphan). Metanalysis of memantine (15 studies) shows little benefit. https://t.co/72yfYzDXhV
QD Clinic - Goldilocks and Osteoarthritis
Whats the Right Ddose for the Right Patient?
Dr. John Cush RheumNow
7 years 7 months ago
Brain fog (Fibro Fog) is common with sleep disorders and fibromyalgia. Manifests as memory problems, poor mental focus, forgetfulness - all correctable with sleep medicine evaluation and sleep assistance. https://t.co/e6CXXkYV39
